BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/31/2019 7:02:25 AM | Browse: 879 | Download: 1533
 |
Received |
|
2019-09-05 00:17 |
|
Peer-Review Started |
|
2019-09-05 00:17 |
|
To Make the First Decision |
|
2019-10-21 02:32 |
|
Return for Revision |
|
2019-10-23 04:24 |
|
Revised |
|
2019-12-02 01:24 |
|
Second Decision |
|
2019-12-06 03:16 |
 |
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2019-12-06 19:37 |
|
Articles in Press |
|
2019-12-06 19:37 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2019-12-14 10:29 |
|
Publish the Manuscript Online |
|
2019-12-31 07:02 |
| ISSN |
1948-5204 (online) |
| Open Access |
This is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Retrospective Study |
| Article Title |
Simultaneous transarterial chemoembolization and radiofrequency ablation for large hepatocellular carcinoma
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Feng Duan, Yan-Hua Bai, Li Cui, Xiao-Hui Li, Jie-Yu Yan and Mao-Qiang Wang |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Mao-Qiang Wang, MD, PhD, Professor, Department of Interventional Radiology, General Hospital of Chinese People’s Liberation Army, No. 28 Fuxing Road, Haidian District, Beijing 100853, China. wangmq@vip.sina.com |
| Key Words |
Chemoembolization; Radiofrequency ablation; Hepatocellular carcinoma; Simultaneous treatment; Transcatheter arterial chemoembolization; Radiofrequency ablation |
| Core Tip |
Hepatocellular carcinoma (HCC) is a common cancer and a leading cause of tumor-related death. Patients who have large HCC (≥ 8 cm) are at advanced stages and have poor prognosis. Interventional treatment including transcatheter arterial chemoembolization (TACE) and radiofrequency ablation (RFA) are commonly used for HCC. However, for patients with large HCC, the use of TACE alone and RFA alone can only lead to partial tumor necrosis with poor local control. Our study showed that simultaneous combination of TACE and RFA may improve therapeutic efficacy and survival for patients with large HCC. |
| Publish Date |
2019-12-31 07:02 |
| Citation |
Duan F, Bai YH, Cui L, Li XH, Yan JY, Wang MQ. Simultaneous transarterial chemoembolization and radiofrequency ablation for large hepatocellular carcinoma. World J Gastrointest Oncol 2020; 12(1): 92-100 |
| URL |
https://www.wjgnet.com/1948-5204/full/v12/i1/92.htm |
| DOI |
https://dx.doi.org/10.4251/wjgo.v12.i1.92 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
